Good company principles

During Corona year 2020 FtV/PAF developed “Good Covid-19 Company Practices (GCCP)”.  The GCCP consists of 18 good practices that pharmaceutical developers / manufacturers of Covid-19 vaccines & therapeutics should undertake to align their actions with human rights principles and international standards for equitable access to medicines.

The aim is to maximize transparent and equitable access to Covid-19 vaccines and therapeutics by monitoring and stimulating companies developing these products to adhere to Good Company Practices.

See our GCCP page